Millie
your market intelligence analyst
Search Results
Edit Save
988 results
SynBioBeta 11/16/2019 06:10
Funding and cooperation advances NovoNutrients’ piloting of its protein-making Carbon Capture and Utilization (CCU) technology to further energy sector sustainability November 13, 2019 10:00 AM Eastern Standard Time SUNNYVALE, Calif.–(BUSINESS WIRE)–NovoNutrients, a Silicon Valley based innovator making protein through carbon capture and utilization, has been selected by Chevron Technology Ventures to join its Catalyst Program.
SynBioBeta 11/15/2019 08:48
Simulation-first approach provides deeper understanding of cancer cells, and supports rational decision-making to unlock new treatments Company’s first institutional funding will be used to expand workflow across all phases of drug discovery November 13, 2019 06:41 AM Eastern Standard Time LONDON & BUDAPEST, Hungary–(BUSINESS WIRE)–Turbine, a simulation-based drug discovery company today announced the closing of [...]. .
SynBioBeta 11/15/2019 08:24
November 14, 2019 09:00 AM Eastern Standard Time – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–X-37, LLC, an artificial intelligence-enabled drug discovery company, announced today that it has closed a $14.5 million Series A financing. The funding round was led by DCVC Bio and was joined by Alpha Intelligence Capital and Hemi Ventures. The Series A funding […]. .
SynBioBeta 11/15/2019 07:23
The future of the synthetic biology industry was on display at the iGEM 2019 Giant Jamboree, held 31 October through 04 November at the Hynes Convention Center in Boston, MA. Showcased were cutting-edge innovations created by the world’s brightest young synthetic biologists from colleges, universities and high schools across the globe. Award-winning projects include the […]. .
SynBioBeta 11/09/2019 05:23
The company also names Dr. Patrick Eimerman Global Head of Marketing and Dr. John Luckey Vice President for Product Development November 05, 2019 01:55 PM Eastern Standard Time PARIS–(BUSINESS WIRE)–DNA Script today announced the acquisition of new office and lab space in South San Francisco, California.
SynBioBeta 11/09/2019 05:12
First-in-class software platform digitalizes Twist Biopharma’s innovative antibody lead identification and optimization November 08, 2019 08:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Twist Biopharma, a division of Twist Bioscience (NASDAQ: TWST), has adopted Genedata Biologics® to support their R&D innovation for [...]. .
SynBioBeta 11/07/2019 12:53
Here is the video of the Inscripta Workshop at SynBioBeta 2019 “Leveraging the power of digital genome engineering” with Nandini Krishnamurthy, Senior Director of Microbial Applications at Inscripta. The Digital Genome Engineering platform from Inscripta dramatically increases the scale of diversity generation by delivering both a large number of edits across the genome as well […]. .
SynBioBeta 11/07/2019 08:19
– Financing led by Fresenius Medical Care Ventures – Proceeds will be used to accelerate lead program in kidney xenotransplant into the clinic and progress a range of other xenotransplant programs across solid organ and cell therapy CAMBRIDGE, Mass. – Nov. 7, 2019 – eGenesis, a biotechnology company utilizing breakthrough gene editing technologies for the [...]. .
SynBioBeta 11/07/2019 06:42
Here is the video of the Inscripta Workshop at SynBioBeta 2019 “Genome-scale mapping of genotype” with Richard Fox, Executive Director of Data Science at Inscripta. Inscripta’s Digital Genome Engineering platform, which includes the first and only automated benchtop instrument of its kind, can be used to interrogate large scale genotype-phenotype relationships and elucidate the causal […]. .
SynBioBeta 11/05/2019 12:12
The Shape Therapeutics RNAfix™ editing platform uses fully human components and avoids risks associated with in vivo CRISPR-based technologies. The SAB, comprised of industry pioneers in the field of genetics and synthetic biology, includes George Church Ph.D. (Harvard-MIT Health Sciences & Technology), James Collins Ph.D. (Harvard-MIT Health Sciences & Technology), and Don Cleveland Ph.D. (UCSD). […]. .
SynBioBeta 11/05/2019 10:12
100% animal-free collagen to revolutionize evolving international beauty markets SAN FRANCISCO – November 4, 2019 — Connell, a Wilbur-Ellis company and a leading marketer and distributor of specialty chemicals and ingredients in Asia-Pacific, announced today it is the exclusive distributor for Geltor, a biodesign company developing high-value designer proteins, starting with collagen.
SynBioBeta 11/04/2019 05:08
The demand for natural products is growing, along with consumers’ increasing attention to the environment and their health. Consumers are seeking brand alternatives that help them make better, more responsible choices, whether to reduce landfill waste or select healthier ingredients. Companies like General Mills, Hershey’s, and Nestlé have heard the message and vowed to eliminate artificial ingredients from foods […]. .

Personal Care

Household Products

Business Issues

Trends

Companies - Public

Companies - Venture Funded

Information Technologies

Regions

Job Titles